prnewswire.com · 17 jun
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggregate of 10,050 shares of its common stock and 11,870 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 18 new employees.
seekingalpha.com · 16 jun
Orbit Makes PTC's Recent Pullback Interesting Despite Execution Risks
PTC Inc. still has a steady and recurring lifecycle software base with offerings across CAD, PLM, ALM, SLM, and general SaaS workflows. Their newer offerings, like Orbit and Jetstream, also move PTC towards a clearer AI integration path for its products and services. I do believe the sale of Kepware and ThingWorx changed its prospects a bit. In part, it streamlined PTC's business and helped finance stock buybacks.
prnewswire.com · 15 jun
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity – – Offering made at 0% interest with conversion price of $107.48, a 40% premium over the closing price on June 15, 2026 – WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the pricing of $500.0 million aggregate principal amount of 0% Convertible Senior Notes due 2031 (the "Notes") in a private placement (the "Offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
prnewswire.com · 15 jun
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity – – Offering to include buyback of common stock – WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the "Notes") in a private placement (the "Offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
prnewswire.com · 11 jun
PTC Launches PTC Orbit, an AI-Powered As-Maintained System of Intelligence for Manufacturers
Enables a complete system of record for asset data, connecting and contextualizing information from various enterprise systems such as PLM, ERP, CRM, IoT, EAM, and FSM systems into a single, unified asset view Built AI-first to surface failure patterns, fleet-level insights, and quality signals that engineering and quality teams can't access today Enables users to explore asset data, investigate issues, and drive action to support reliability and revenue-focused campaigns BOSTON, June 11, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the PTC Orbit™ cloud-native asset intelligence solution, which closes the gap between the product as designed and the asset as maintained. By connecting PLM, ERP, CRM, IoT, EAM, and FSM systems into a single, unified asset record, PTC Orbit applies AI to make asset information accessible, explorable, and actionable across engineering, quality, and service teams and extends the value of the Intelligent Product Lifecycle.
prnewswire.com · 10 jun
PTC Unveils a Wave of Product Innovations to Give Manufacturers New AI Capabilities and Connected Tools Across the Intelligent Product Lifecycle
Introduces PTC Orbit and PTC Jetstream, a new AI platform, 12 AI agents, 10 new integrations, and 100+ enhancements across CAD, PLM, ALM, and SLM solutions Delivers the Intelligence Layer across the portfolio, giving manufacturers a stronger foundation for product data, deeper AI capabilities, and a more connected Intelligent Product Lifecycle PTC NEXT provides comprehensive portfolio updates twice a year, giving customers a predictable cadence to stay ahead and move forward with building their Intelligent Product Lifecycle CHICAGO, June 10, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced its latest wave of product innovations to help customers move faster, build smarter products, and unlock more value from their data. Unveiled this week at the PTC NEXT™ Chicago event, the innovations include two new cross-portfolio products, a new AI platform, 12 new AI agents, 10 new integrations, and major updates to every product in PTC's portfolio, further advancing its Intelligent Product Lifecycle vision in ways customers can act on today.
prnewswire.com · 10 jun
PTC Brings AI-Powered Guidance to the Design Environment with Creo 13
AI Assistant provides engineering guidance, best practices, and troubleshooting information, reducing onboarding time and reliance on external documentation Beta: AI that reads your 3D model to help teams catch issues earlier and validate designs faster Hundreds of enhancements across design, simulation, and manufacturing, reducing repetitive work and enabling accelerated workflows BOSTON, June 10, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the release of Creo 13 and Creo+ 13.3, the latest versions of its on-prem and SaaS Creo® computer-aided design (CAD) solution. The release introduces the Creo AI Assistant, along with hundreds of enhancements across model-based product development, simulation-driven design, and manufacturing, to help engineering teams deliver better designs in less time.